KRAS and squamous cell lung carcinoma: Depending on the population and the series, the frequency of KRAS mutations in lung cancer patients is variable, identified in around 20% to 40% of lung adenocarcinomas and in around 5% to 7% of lung squamous cell lung carcinomas [58,59,60,61,62,63,64,65].